Billionaires George Soros and James Dinan Love These Stocks

The next in the list is Allergan PLC (NYSE:AGN), in which Soros increased his holding of the shares by 30% over the first three months of the year, lifting the total to 417,367 shares valued at $124.22 million. On June 4, Bank of America Merrill Lynch reported an increase in the target price of the pharmaceutical giant to $350 per share. The investment bank believes that the stock still has 14-15% upside potential, as the growth potential has not been fully priced-in yet. York Capital Management owns around 1.53 million shares of Allergan PLC (NYSE:AGN), valued at $454.53 million. Allergan, then known still as Actavis, ranked as the most popular stock among the hedge funds tracked by Insider Monkey, as well as by the billionaires tracked by Insider Monkey.

Following a hike of 27% to his holding in Endo International plc (NASDAQ:ENDP), Soros owned 2.22 million shares valued at $198.88 million on March 31. Endo International plc (NASDAQ:ENDP) is an Ireland-based company that manufactures and sells pharmaceutical products, the biggest of which are Lidoderm, Opana, Voltaren, and Percocet. Over the current year, the shares of the Irish company have appreciated by 12.69% and still have the potential to realize greater upside due to Endo management’s decision to develop a generic pharmaceuticals division. York Capital Management initiated its position in this stock during the first quarter, and holds 1.88 million shares worth $168.80 million as of March 31.

Lastly, Soros Fund Management held 1.23 million shares of DISH Network Corp (NASDAQ:DISH) valued at some $85.95 million. DISH Network Corp (NASDAQ:DISH) is a provider of pay-television services in the United States. Over the last year, there were rumors and speculations about the potential mergers of this company with both DirecTV (NASDAQ:DTV) and Verizon Communications Inc. (NYSE:VZ), though none of them materialized. Now, the company has seemingly found its match with T-Mobile US (NYSE: TMUS), but the potential deal is in the very early stages and the information is still coming from anonymous sources, so we have to wait and see how it plays out. James Dinan is the second-largest shareholder in this company among the fund managers that we track, holding 5.30 million shares valued at $371.17 million.

Disclosure: None